Dr. Balachandran’s research team has looked into pancreatic cancer survivors, wondering why some patients do much better against pancreatic cancer. Compared with pancreatic tumors from people who had low survival rates, tumors from long-term survivors had nearly 12 times the number of immune cells called T cells inside them.Read More about Long-Term Pancreatic Cancer Survivors